Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug Administration a little more than a week after he left the agency.

The word from the FDA is that Prasad has come back at the request of the regulator's Commissioner, Marty Makary, who appointed Prasad to the CBER position in May. Endpoints first reported his return on Saturday, and that was confirmed by the FDA shortly thereafter.

Vinay Prasad, who was ousted as the top vaccine and gene therapy regulator at the US Food and Drug Administration, is returning to his role, the Department of Health and Human Services said Sunday.